Engineers Gate Manager LP Biogen Inc. Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

A detailed history of Engineers Gate Manager LP transactions in Biogen Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 17,992 shares of BIIB stock, worth $2.68 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
17,992
Holding current value
$2.68 Million
% of portfolio
0.07%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$189.07 - $236.8 $3.4 Million - $4.26 Million
17,992 New
17,992 $3.49 Million
Q1 2024

May 15, 2024
BUY
$212.02 - $267.71 $8.45 Million - $10.7 Million
39,840 New
39,840 $8.59 Million
Q1 2023

May 15, 2023
SELL
$256.56 - $292.34 $727,091 - $828,491
-2,834 Reduced 45.01%
3,462 $962,000
Q4 2022

Feb 14, 2023
BUY
$252.44 - $306.72 $920,648 - $1.12 Million
3,647 Added 137.67%
6,296 $1.74 Million
Q3 2022

Nov 14, 2022
SELL
$194.69 - $268.46 $2.14 Million - $2.95 Million
-10,982 Reduced 80.57%
2,649 $707,000
Q2 2022

Aug 15, 2022
BUY
$187.54 - $223.02 $430,404 - $511,830
2,295 Added 20.25%
13,631 $2.78 Million
Q1 2022

May 16, 2022
BUY
$193.77 - $244.14 $1.96 Million - $2.46 Million
10,095 Added 813.46%
11,336 $2.39 Million
Q4 2021

Feb 14, 2022
SELL
$223.92 - $287.77 $330,058 - $424,172
-1,474 Reduced 54.29%
1,241 $298,000
Q3 2021

Nov 15, 2021
BUY
$282.99 - $369.05 $15,564 - $20,297
55 Added 2.07%
2,715 $768,000
Q2 2021

Aug 16, 2021
BUY
$259.0 - $414.71 $688,940 - $1.1 Million
2,660 New
2,660 $921,000
Q1 2021

May 17, 2021
SELL
$242.95 - $284.63 $3.14 Million - $3.67 Million
-12,908 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$236.26 - $355.63 $2.6 Million - $3.92 Million
11,011 Added 580.44%
12,908 $3.16 Million
Q3 2020

Nov 16, 2020
SELL
$264.77 - $305.71 $1.86 Million - $2.15 Million
-7,041 Reduced 78.78%
1,897 $538,000
Q2 2020

Aug 17, 2020
BUY
$258.66 - $342.55 $2.05 Million - $2.71 Million
7,908 Added 767.77%
8,938 $2.39 Million
Q1 2020

May 15, 2020
SELL
$268.85 - $341.04 $4.08 Million - $5.17 Million
-15,174 Reduced 93.64%
1,030 $326,000
Q4 2019

Feb 14, 2020
BUY
$220.06 - $304.07 $793,976 - $1.1 Million
3,608 Added 28.64%
16,204 $4.81 Million
Q3 2019

Nov 14, 2019
BUY
$217.44 - $243.88 $2.74 Million - $3.07 Million
12,596 New
12,596 $2.93 Million
Q2 2019

Aug 14, 2019
SELL
$219.29 - $241.72 $2.26 Million - $2.49 Million
-10,300 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$216.71 - $338.96 $2.23 Million - $3.49 Million
10,300 New
10,300 $2.44 Million

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email